how to use glp-1 weight loss oral solution A New Option in Management A new once-daily GLP-1, orforglipron (Foundayo™) was FDA approved on April 1, 2026 ATTAIN-1 Trial: ~12.4% average weight (~27 lbs) and Improved cholesterol + GLP-1 Medications: Everything You Need

Medical Condition Contrave is FDA-approved for weight management in people with a body mass index (BMI) of more than 30, or a BMI of more than 27 with another weight-related condition, like high blood pressure, Type 2 diabetes, or high cholesterol

Additionally, their under-development triple agonist, Retatrutide, has shown unprecedented weight loss effects in phase 2 clinical trials

The tradeoff involves regulatory risk, shipping complications, potential customs seizure, and less recourse if quality issues arise

[PubMed] [Google Scholar] 82.Huang J., Jia Y., Sun S., Meng L

However, unlike Ozempic, Wegovy is FDA-approved for chronic weight management

Understanding GLP-1 Medications What Are GLP-1 Medications